Cabaletta Bio, Inc.
CABA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001759138
No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Cabaletta Bio, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 54 | 61 | +7 |
| Shares | 11.9M | 19.9M | +7.94M (+66.5%) |
| Value | $7.76M | $183.9M | +$176.1M (+2,271.0%) |
New holders (24)
Institutions that held Cabaletta Bio, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (17)
Institutions that held Cabaletta Bio, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Privium Fund Management (UK) Ltd | 331,218 | $215.0K |
| Acadian Asset Management LLC | 147,480 | $95.0K |
| Harbor Capital Advisors, Inc. | 143,629 | $93.0K |
| Two Sigma Advisers, LP | 54,400 | $35.0K |
| Victory Capital Management Inc | 42,586 | $28.0K |
| Simplex Trading, LLC | 24,310 | $15.0K |
| Two Sigma Securities, LLC | 13,594 | $9.00K |
| Virtu Financial LLC | 14,070 | $9.00K |
| Goldman Sachs Group Inc | 10,996 | $7.00K |
| BIT Capital GmbH | 10,000 | $6.50K |
| Group One Trading, L.P. | 6,373 | $4.00K |
| Federated Hermes, Inc. | 1,591 | $1.00K |
| First Manhattan Co | 500 | $0 |
| Citigroup Inc | 340 | $0 |
| Daiwa Securities Group Inc. | 45 | $0 |
| Cutler Group LP | 600 | $0 |
| China Universal Asset Management Co., Ltd. | 272 | $0 |